New Vaccine Protects Against Staph, Drug-Resistant MRSA

A new vaccine developed by researchers at the University of Iowa in Iowa City protects patients against lethal pneumonia caused by Staphylococcus aureus bacteria and drug-resistant Methicillin-resistant Staphylococcus aureus, according to a news release from the University of Iowa.

Researchers using an animal model found vaccination against three staph toxins almost completely protect against staph infections. Additionally, after introducing the vaccine, disease-causing bacteria were completely eliminated from the animal’s lungs.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

Previous attempts to target staph vaccines have focused on the cell-surface proteins on bacteria instead of staph toxins, according to the report. Researchers found vaccines focused on cell-surface proteins tend to increase the severity of the infection while the newly developed vaccine that targets staph toxins almost completely protects against staph infections.

More Articles on HAIs:

10 Hand Hygiene Posters to Hang in Your Facility
Many Treated for C. diff Not Actually Infected
Hospital Compare Adds C. diff, MRSA Data

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars